Science Applications AI Stock Analysis
Want to see SAIC full AI Analyst Report?
Science Applications (SAIC) AI Stock Analysis
Science Applications
(NASDAQ:SAIC)
SAIC scores solidly on strong free-cash-flow generation and a technically healthy uptrend (price above key moving averages with supportive momentum). The score is tempered by moderate profitability with margin compression versus 2024 and mixed balance-sheet signals around leverage/equity trends, while valuation is reasonable and recent corporate actions are generally positive but not transformational.
Science Applications Key Performance Indicators (KPIs)
Total BacklogIndicates the total value of contracted work yet to be completed, highlighting future revenue streams and the company's ability to secure long-term projects.
Backlog has traded in a roughly $22–24B band since 2021, dipping in 2024 then recovering through 2025—suggesting steady contract visibility rather than a breakout. That pickup aligns with Q1 book‑to‑bill >1 and a large $85B qualified pipeline, which helps explain the margin and cash improvements; however, management’s warning about the RITS recompete, a trimmed enterprise‑IT funnel and slower RFP timing means backlog may sustain revenue visibility but won't guarantee stronger organic growth without improved bookings and recompete wins.
Science Applications (SAIC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.06B
- Dividend Yield
- 1.02%
- Average Volume (3M)
- 456.22K
- Price to Earnings (P/E)
- 16.7
- Beta (1Y)
- 0.35
- Revenue Growth
- -0.78%
- EPS Growth
- 3.90%
- Country
- US
- Employees
- 23,000
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Information Technology Services
Science Applications Business Overview & Revenue Model
Company Description
Science Applications International Corporation (SAIC), a U.S.-based firm, specializes in providing a wide array of advanced technical, engineering, and comprehensive information technology (IT) solutions. Its diverse offerings span crucial areas such...
How the Company Makes Money
SAIC primarily makes money by performing services and delivering technology solutions under contracts with U.S. government agencies. Revenue is recognized as contract work is performed and deliverables/services are provided, and the company’s earning...
Science Applications Earnings Call Summary
The call emphasized strong operational execution in Q1 — record margins, robust adjusted EBITDA ($222M), improved civil margins (~15%), upgraded EPS and EBITDA guidance, solid free cash flow generation and active capital return via buybacks. Management remains cautious on sales for FY27 due to recompete timing (notably RITS), a smaller/reshaped enterprise IT pipeline, slower RFP timing and election-year/appropriations uncertainty. While some margin upside in the quarter was aided by a one-time venture gain, underlying cash flow and deleveraging progress are clear. Overall, the company appears to be making deliberate strategic changes (portfolio and pipeline focus) and has momentum on margins and cash, but faces identifiable timing and organic growth risks that management is actively managing.
Q1-2027 Updates
Positive Updates
Negative Updates
Company Guidance
SAIC maintained its FY2027 sales guidance but raised profitability and EPS outlook after a strong F1Q: Q1 revenue $1.9B (+0.5% organic), adjusted EBITDA $222M (included $12M venture IPO gain that added ~60bps to EBITDA margin and ~$0.20 to EPS), adjusted diluted EPS $3.23, free cash flow $118M, net leverage down to 3.1x, net bookings $2.1B (book‑to‑bill 1.1x; 1.0x TTM) and a qualified pipeline of ~$85B. Management raised full‑year adjusted EBITDA margin guidance to 10.1%–10.3% (up ~20bps), increased adjusted EPS guidance ~4% to $9.90–$10.10, reiterated FCF >$600M and at least $14 FCF/share in FY27 (and ≥$13 in FY28), expects on‑contract growth of 2%–3%, will revisit organic growth (previous guide −2% to −4%) at Q2, repurchased $188M this quarter toward a ~ $400M buyback plan, and said the ~$200M RITS recompete headwind will likely roll off in Q3 (implying roughly a ~3% organic drag in each of Q3 and Q4).
Science Applications Financial Statement Overview
Summary
Cash flow is the standout (TTM FCF $619M with strong growth and ~0.94x conversion vs net income), supporting earnings quality. However, profitability is only moderate (TTM net margin ~5.1%, EBIT margin ~8.0%) and margins have compressed versus 2024 levels, while balance-sheet trends show caution flags (historically higher debt-to-equity and declining equity in annual figures despite strong ROE).
Income Statement
67PositiveBalance Sheet
60NeutralCash Flow
74Positive| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.40B | 7.26B | 7.48B | 7.44B | 7.70B | 7.39B |
| Gross Profit | 936.00M | 879.00M | 892.00M | 872.00M | 888.00M | 859.00M |
| EBITDA | 749.00M | 661.00M | 686.00M | 882.00M | 650.00M | 628.00M |
| Net Income | 380.00M | 358.00M | 362.00M | 477.00M | 300.00M | 277.00M |
Balance Sheet | ||||||
| Total Assets | 5.42B | 5.35B | 5.25B | 5.31B | 5.54B | 5.75B |
| Cash, Cash Equivalents and Short-Term Investments | 126.00M | 182.00M | 56.00M | 94.00M | 109.00M | 106.00M |
| Total Debt | 2.71B | 2.71B | 2.39B | 2.25B | 2.53B | 2.71B |
| Total Liabilities | 3.99B | 3.85B | 3.67B | 3.53B | 3.84B | 4.12B |
| Stockholders Equity | 1.44B | 1.50B | 1.58B | 1.78B | 1.69B | 1.62B |
Cash Flow | ||||||
| Free Cash Flow | 619.00M | 577.00M | 458.00M | 369.00M | 507.00M | 482.00M |
| Operating Cash Flow | 660.00M | 609.00M | 494.00M | 396.00M | 532.00M | 518.00M |
| Investing Cash Flow | -240.00M | -248.00M | -35.00M | 314.00M | -36.00M | -292.00M |
| Financing Cash Flow | -342.00M | -235.00M | -498.00M | -725.00M | -493.00M | -301.00M |
Science Applications Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SAIC, the sentiment is Neutral. The current price of 144.73 is below the 20-day moving average (MA) of 148.65, above the 50-day MA of 137.70, and above the 200-day MA of 112.89, indicating a neutral trend. The MACD of 3.37 indicates Positive momentum. The RSI at 49.92 is Neutral, neither overbought nor oversold. The STOCH value of 45.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SAIC.
Science Applications Risk Analysis
Science Applications disclosed 29 risk factors in its most recent earnings report. Science Applications reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
2 New RisksScience Applications Peers Comparison
Overall Rating
ACN84Outperform
IBM79Outperform
LDOS73Outperform
CACI72Outperform
SAIC71Outperform
PSN67Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | $141.42B | 17.63 | 26.77% | 2.76% | 6.47% | 11.19% | |
| 79Outperform | $218.41B | 19.45 | 32.95% | 2.92% | 6.83% | 39.80% | |
| 73Outperform | $15.65B | 11.39 | 28.04% | 1.34% | 2.67% | 4.32% | |
| 72Outperform | $13.86B | 25.51 | 12.37% | ― | 10.12% | 7.58% | |
| 71Outperform | $6.06B | 16.72 | 25.89% | 1.02% | -0.78% | 3.90% | |
| 67Neutral | $5.34B | 36.58 | 5.58% | ― | -2.67% | -61.86% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SAIC | Science Applications International Corp. | 144.73 | 60.10 | 71.02% | |
| ACN | Accenture Plc | 239.28 | 6.31 | 2.71% | |
| CACI | Caci International | 624.01 | 21.16 | 3.51% | |
| IBM | International Business Machines Corporation | 231.09 | -49.74 | -17.71% | |
| LDOS | Leidos Holdings Inc | 128.25 | -58.76 | -31.42% | |
| PSN | Parsons Corp | 50.64 | -32.65 | -39.20% |
Science Applications Corporate Events
Science Applications Completes $500 Million Senior Notes Offering
NeutralOn November 13, 2026, Science Applications International Corporation closed a private offering of $500 million aggregate principal amount of 6.750% senior notes due 2034, receiving approximately $493 million in net proceeds after discounts and estima...
SAIC Prices $500 Million Senior Notes Offering
NeutralOn November 2, 2026, SAIC announced it had commenced and priced a private offering of $500 million in senior notes due 2034. The announced use of proceeds was to redeem all outstanding 4.875% senior notes due 2028 and cover offering costs, with remai...
Science Applications announces key executive leadership appointments
PositiveOn Oct. 13, 2026, SAIC announced two senior leadership changes designed to bolster its executive bench and support long-term growth. Prabu Natarajan, previously serving as interim head, was appointed permanent Executive Vice President of the Civilian...
Science Applications Declares Quarterly Cash Dividend, Signals Confidence
PositiveOn August 27, 2026, Science Applications International Corp.’s board of directors declared a cash dividend of $0.37 per share on its common stock, payable on October 23, 2026 to shareholders of record as of October 9, 2026. The decision reinforces SA...
Science Applications Expands Government Receivables Financing Capacity
PositiveOn August 14, 2026, Science Applications International Corporation amended its Master Accounts Receivable Purchase Agreement with MUFG Bank, Ltd., raising the facility limit for certain eligible U.S. government receivables from $300 million to $400 m...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 13, 2026
